Publications by authors named "Edward Copelan"

Claim this Profile
P
Pretransplant Conditioning for Hematopoietic Cell Transplants: The Past Is Prologue.
Edward A Copelan, Belinda R Avalos, Robert P Gale

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic cell transplantation in first relapse of (CBF- and other) AML.
Edward A Copelan, Robert P Gale

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
upregulation via aurora kinase inhibition overcomes primary failure to venetoclax in rearranged lymphomas.
Rajeswaran Mani, Samon Benrashid, Margaret D Templeton, Lawrence J Druhan, Sara L Seegers, Edward A Copelan

iScience· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice.
Nilanjan Ghosh, Ashley Matusz-Fisher, Rupali Bose, Danielle Boselli, Gray Magee, Edward Copelan

JCO Oncol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Miranda Benfield, Jiaxian He, Justin Arnall, Whitney Kaizen, Elizabeth Jandrisevits, Edward Copelan

Transplant Cell Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the PROS.
Edward Copelan, Robert P Gale

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Michael R Grunwald, Wei Sha, Jiaxian He, Srinivasa Sanikommu, Jonathan M Gerber, Edward Copelan

Transplant Cell Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders.
Saad Z Usmani, Nilanjan Ghosh, Peter Voorhees, Edward Copelan

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma.
Bei Hu, Rakhee Vaidya, Ferdous Ahmed, Hamid Ehsan, Tamara K Moyo, Edward A Copelan

Transplant Cell Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy.
David M Foureau, Fei Guo, Nury M Steuerwald, Lawrence J Druhan, Belinda R Avalos, Edward Copelan

Exp Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
Hemant S Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Edward Copelan

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing.
Jai N Patel, Myra Robinson, Sarah A Morris, Elizabeth Jandrisevits, Karine Eboli Lopes, Edward Copelan

Pharmacogenomics J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pentamidine tolerability and efficacy between phenotypes.
Alexis Koon, Jiaxian He, Jai Patel, Allison Morse, Victoria Boseman, Edward Copelan

Pharmacogenomics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplantation and cellular therapy in acute leukemia.
Michael Grunwald, Belinda Avalos, Edward Copelan

Best Pract Res Clin Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients.
Zainab Shahid, Alicia L Patrick, Michelle L Wallander, Erin E Donahue, Sally J Trufan, Edward A Copelan

Vaccine X· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.
Betty K Hamilton, Lisa A Rybicki, Hong Li, Taylor Lucas, Donna Corrigan, Edward A Copelan

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Edward A Copelan

Leukemia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients.
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Edward A Copelan

Leukemia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Matthew Mei, Raju Pillai, Soyoung Kim, Noel Estrada-Merly, Michelle Afkhami, Edward Copelan

Haematologica· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy.
Thomas G Knight, Melissa Aguiar, Myra Robinson, Allison Morse, Tommy Chen, Edward A Copelan

JCO Oncol Pract· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax.
Aleksander L Chojecki, Justin Arnall, Danielle Boselli, Rushil Patel, Zane Chiad, Edward A Copelan

Leuk Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF).
Aleksander L Chojecki, Kristyn Y DiSogra, Justin Arnall, Nicole Cowgill, Amy Soni, Edward A Copelan

Leuk Lymphoma· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
Antonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, Trent P Wang, Mei-Jie Zhang, Edward Copelan

Bone Marrow Transplant· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
Matthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, Hai-Lin Wang, Noel Estrada-Merly, Edward Copelan

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
Antonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, Trent P Wang, Mei-Jie Zhang, Edward Copelan

Bone Marrow Transplant· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis